International Journal of Cell Biology [42] L. Xiao, D. Chen, P. Hu et al., “The c-Abl-MST1 signaling pathway mediates oxidative stress-induced neuronal cell death,” Journal of Neuroscience, vol. 31, no. 26, pp. 9611–9619, 2011. [43] K. Banerjee, M. Sinha, C. L. L. Pham et al., “α-Synuclein induced membrane depolarization and loss of phosphoryla- tion capacity of isolated rat brain mitochondria: implications in Parkinson’s disease,” FEBS Letters, vol. 584, no. 8, pp. 1571– 1576, 2010. [44] E. Wong and A. M. Cuervo, “Autophagy gone awry in neurodegenerative diseases,” Nature Neuroscience, vol. 13, no. 7, pp. 805–811, 2010. [45] I. U. Song, Y. D. Kim, H. J. Cho, S. W. Chung, and Y. A. Chung, “An FP-CIT PET comparison of the diﬀerences in dopamin- ergic neuronal loss between idiopathic Parkinson disease with dementia and without dementia,” Alzheimer Disease and Associated Disorders. In press. [46] G. Yogalingam and A. M. Pendergast, “Abl kinases regulate autophagy by promoting the traﬃcking and function of lysosomal components,” The Journal of Biological Chemistry, vol. 283, no. 51, pp. 35941–35953, 2008. [47] A. Ertmer, V. Huber, S. Gilch et al., “The anticancer drug imatinib induces cellular autophagy,” Leukemia, vol. 21, no. 5, pp. 936–942, 2007. [48] K. Nihira, N. Taira, Y. Miki, and K. Yoshida, “TTK/Mps1 con- trols nuclear targeting of c-Abl by 14-3-3-coupled phosphory- lation in response to oxidative stress,” Oncogene, vol. 27, no. 58, pp. 7285–7295, 2008. [49] Y. Ito, P. Pandey, N. Mishra et al., “Targeting of the c-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis,” Molecular and Cellular Biology, vol. 21, no. 18, pp. 6233–6242, 2001. [50] S. Kumar, A. Bharti, N. C. Mishra et al., “Targeting of the c-Abl tyrosine kinase to mitochondria in the necrotic cell death response to oxidative stress,” The Journal of Biological Chemistry, vol. 276, no. 20, pp. 17281–17285, 2001. [51] S. Kumar, N. Mishra, D. Raina, S. Saxena, and D. Kufe, “Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571,” Molecular Pharmacology, vol. 63, no. 2, pp. 276–282, 2003. [52] M. Lasfer, L. Davenne, N. Vadrot et al., “Protein kinase PKC delta and c-Abl are required for mitochondrial apoptosis induction by genotoxic stress in the absence of p53, p73 and Fas receptor,” FEBS Letters, vol. 580, no. 11, pp. 2547–2552, 2006. [53] D. Gioeli, “The dynamics of the cell signaling network; implications for targeted therapies,” in Targeted Therapies Mechanisms of Resistance, pp. 33–53, Humana, Clifton, NJ, USA, 2011. [54] F. J. Adria´n, Q. Ding, T. Sim et al., “Allosteric inhibitors of Bcr- abl-dependent cell proliferation,” Nature Chemical Biology, vol. 2, no. 2, pp. 95–102, 2006. [55] J. Zhang, F. J. Adria´n, W. Jahnke et al., “Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors,” Nature, vol. 463, no. 7280, pp. 501–506, 2010. [56] R. E. Iacob, J. Zhang, N. S. Gray, and J. R. Engen, “Allosteric interactions between the myristate- and ATP-site of the Abl kinase,” PLoS ONE, vol. 6, no. 1, Article ID e15929, 2011. [57] M. Preyer, P. Vigneri, and J. Y. J. Wang, “Interplay between kinase domain autophosphorylation and F-actin binding domain in regulating imatinib sensitivity and nuclear import of BCR-ABL,” PLoS ONE, vol. 6, no. 2, Article ID e17020, 2011. [58] Y. Choi, M. A. Seeliger, S. B. Panjarian et al., “N-myristoylated c-Abl tyrosine kinase localizes to the endoplasmic reticulum 7 upon binding to an allosteric inhibitor,” The Journal of Biological Chemistry, vol. 284, no. 42, pp. 29005–29014, 2009. [59] E. Balogun, M. Hoque, P. Gong et al., “Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element,” Biochemical Journal, vol. 371, no. 3, pp. 887–895, 2003. [60] E. Lloyd-Evans, A. J. Morgan, X. He et al., “Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium,” Nature Medicine, vol. 14, no. 11, pp. 1247–1255, 2008.